Misalignment of global COVID-19 breastfeeding and newborn care guidelines with World Health Organization

Duong Vu Hoang1, Jennifer Cashin2, Karleen Gribble3

  • 1Alive & Thrvie Southeast Asia, FHI 360, Hanoi, Vietnam.

Insights

International COVID-19 guidance for new mothers and infants showed significant inconsistencies, often undermining breastfeeding and maternal proximity. Policies must prioritize infant health by supporting breastfeeding and skin-to-skin contact during infectious disease outbreaks.

Area of Science:

  • Public Health
  • Infectious Disease Management
  • Maternal and Child Health

Background:

  • Clinical management guidance for mothers with COVID-19 and their infants is essential.
  • Balancing SARS-CoV-2 transmission risk with benefits of maternal proximity and breastfeeding is critical.
  • Reviewing international COVID-19 guidance for maternal/newborn care assesses alignment with WHO recommendations on breastfeeding support.

Purpose of the Study:

  • To review international COVID-19 guidance for maternal and newborn care.
  • To assess alignment with World Health Organization (WHO) recommendations.
  • To determine the extent to which policies supported or undermined breastfeeding.

Main Methods:

  • Assessed guidance documents from 33 countries for care of infants with mothers suspected/confirmed COVID-19.
  • Evaluated alignment with WHO recommendations on skin-to-skin contact, breastfeeding initiation/continuation, rooming-in, and psychological support.
  • Included assessment of provision of expressed/donor milk and breastmilk substitutes.

Main Results:

  • Found considerable inconsistency in international recommendations.
  • Identified common recommendations against breastfeeding-supportive practices, even in high infant mortality countries.
  • Observed that no reviewed guidance fully aligned with all WHO recommendations, indicating undervaluation of maternal proximity and breastfeeding.

Conclusions:

  • Guidance for infectious disease outbreaks must prioritize skin-to-skin contact, breastfeeding, and rooming-in for maternal/infant well-being.
  • Future guidance development should consider the reliability and breastfeeding value of existing recommendations.
  • Recommendations against maternal proximity/breastfeeding require compelling evidence of necessity and lower harm than maintaining dyad integrity.
Abstract

Related Concept Videos

International Nursing Organizations I01:23

International Nursing Organizations I

International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...